Literature DB >> 6246033

Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma.

Z Yi, L Yuxi, L Chunren, C Sanwen, W Jihneng, Z Jisong, Z Huijong.   

Abstract

The frequency of IgA antibody to virus capsid antigen (VCA) of EB virus was tested by an immunoenzymatic method among adults in a mass serological screening of the general population of 6 communes in South China, as a guide toward early detection of nasopharyngeal carcinoma. Sera from 56 patients already recognized as having nasopharyngeal carcinoma (NPC) also were tested. The screening was conducted with sera from 56,584 persons age 30 years and older in Zangwu County in the Guangsi Zhuang Autonomous Region. IgA antibody to VCA was found in 96% of the NPC patients tested; the geometric mean antibody titer for this group was 1:41. The antibody also was detected in 117 of the persons surveyed in the mass screening, and among these, the geometric mean antibody titer was 1:21. 20 of the antibody-positive persons were diagnosed by clinical and pathological examination as having NPC. 18 of these cases were diagnosed soon after the initial tests in June-September, 1978, and an additional 2 were diagnosed only after follow-up examinations 10 months after the first blood sample was taken. All of the persons who are in the antibody-positive group but exhibit no detectable tumors are to be reexamined periodically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246033     DOI: 10.1159/000149121

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  14 in total

Review 1.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

2.  Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.

Authors:  Su-Mei Cao; Zhiwei Liu; Wei-Hua Jia; Qi-Hong Huang; Qing Liu; Xiang Guo; Teng-Bo Huang; Weimin Ye; Ming-Huang Hong
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

3.  Early detection of nasopharyngeal carcinoma.

Authors:  Keiji Tabuchi; Masahiro Nakayama; Bungo Nishimura; Kentaro Hayashi; Akira Hara
Journal:  Int J Otolaryngol       Date:  2011-06-08

4.  The clinical illness promotion factor: a third ingredient.

Authors:  A S Evans
Journal:  Yale J Biol Med       Date:  1982 May-Aug

5.  Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models.

Authors:  H H Chen; T C Prevost; S W Duffy
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

6.  Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.

Authors:  Yufeng Chen; Weilin Zhao; Longde Lin; Xue Xiao; Xiaoying Zhou; Huixin Ming; Tingting Huang; Jian Liao; Yancheng Li; Xiaoyun Zeng; Guangwu Huang; Weimin Ye; Zhe Zhang
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

7.  The Chinese epidemiological approach of nasopharyngeal carcinoma research and control.

Authors:  G De-Thé
Journal:  Yale J Biol Med       Date:  1981 Jan-Feb

8.  Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.

Authors:  M F Ji; D K Wang; Y L Yu; Y Q Guo; J S Liang; W M Cheng; Y S Zong; K H Chan; S P Ng; W I Wei; D T T Chua; J S T Sham; M H Ng
Journal:  Br J Cancer       Date:  2007-02-06       Impact factor: 7.640

9.  Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study.

Authors:  Jin-Lin Du; Sui-Hong Chen; Qi-Hong Huang; Shang-Hang Xie; Yan-Fang Ye; Rui Gao; Jie Guo; Meng-Jie Yang; Qing Liu; Ming-Huang Hong; Su-Mei Cao
Journal:  Chin J Cancer       Date:  2016-08-15

10.  Evaluation of seven recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal carcinoma in China: a case-control trial.

Authors:  Rui Gao; Lin Wang; Qing Liu; Li-Fang Zhang; Yan-Fang Ye; Shang-Hang Xie; Jin-Lin Du; Sui-Hong Chen; Jie Guo; Meng-Jie Yang; Chu-Yang Lin; Su-Mei Cao
Journal:  BMJ Open       Date:  2017-07-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.